4.3.2015
•
News
KŠB once again nominated for Chambers Europe Award
Despite stricter rules this year, KŠB was once again nominated for one of the most prestigious awards in the world of legal ratings, the Chambers Europe Award, which is given by British ratings agency Chambers and Partners.
This year’s nomination is even more esteemed since the competition organizers changed the nomination system for the Czech Republic. This year, Czech and foreign law firms are no longer rated separately but are instead rated together in one combined category. KŠB is the only purely Czech law firm that is included in the list of nominated law firms.
The holder of this year’s award on behalf of the Czech Republic will be announced on Friday, 24 April 2015 at the awards ceremony held at the Amsterdam Okura hotel.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
